Mary Hahn
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
-
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- TGF-β signaling in diseases 1
- Histone Deacetylase Inhibitors Research 1
- Signaling Pathways in Disease 1
- Oncology 3
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Dingcheng Gao (3 shared papers)Raúl Catena (3 shared papers)Vivek Mittal (3 shared papers)Hyejin Choi (2 shared papers)Linda T. Vahdat (2 shared papers)Natasha Joshi (2 shared papers)Seongho Ryu (2 shared papers)Luena Papa (1 shared paper)
- Journals
- Cancer Research (2 papers)Neuro-Oncology (1 paper)Journal of Biological Chemistry (1 paper)Cancer Cell (1 paper)Cancer Research Communications (1 paper)
- Partner nations
- United StatesAustraliaSouth Korea
In The Last Decade
Mary Hahn
7 papers receiving 527 citations
Peers
Comparison fields: 5 of 66
- Cancer Research 197
- Oncology 202
- Immunology 107
- Immunology and Allergy 26
- Molecular Biology 294
Countries citing papers authored by Mary Hahn
This map shows the geographic impact of Mary Hahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Hahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Hahn more than expected).
Fields of papers citing papers by Mary Hahn
This network shows the impact of papers produced by Mary Hahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Hahn. The network helps show where Mary Hahn may publish in the future.
Co-authors
The 25 scholars most cited alongside Mary Hahn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 234 | |
| 2 | 2013 | 126 | |
| 3 | 2014 | 107 | |
| 4 | 2010 | 41 | |
| 5 | 2023 | 19 | |
| 6 | 2021 | 3 | |
| 7 | Development of a tetracycline-inducible system for expression of the Ca2+ permeable TRPL channel and the killing of prostate cancer cells | 2004 | 1 |
About Mary Hahn
Mary Hahn is a scholar working on Molecular Biology, Oncology, Cancer Research, Genetics and Physiology, having authored 7 papers that have together received 531 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer Genomics and Diagnostics (1 paper), MicroRNA in disease regulation (1 paper), TGF-β signaling in diseases (1 paper), Cancer, Hypoxia, and Metabolism (1 paper), Histone Deacetylase Inhibitors Research (1 paper) and Signaling Pathways in Disease (1 paper). The work is most often cited by research in Cancer Research (197 citations), Oncology (202 citations), Immunology (107 citations), Immunology and Allergy (26 citations) and Molecular Biology (294 citations). Mary Hahn has collaborated with scholars based in United States, Australia and South Korea. Frequent co-authors include Dingcheng Gao, Raúl Catena, Vivek Mittal, Hyejin Choi, Linda T. Vahdat, Natasha Joshi, Seongho Ryu, Luena Papa, Ellen L. Marsh and Doris Germain. Their work appears in journals such as Cancer Research, Neuro-Oncology, Journal of Biological Chemistry, Cancer Cell and Cancer Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.